Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period

NCT02587195

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHU de Besançon Besançon, France
  • CHU de Lille Lille, France
  • CHU de Montpellier Montpellier, France
  • CHU de Nice Nice, France
View Trial Details
Completed

Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome

NCT03122652

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • CHU de Bordeaux Bordeaux, France
  • CHU de Caen Caen, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
  • CHU de Grenoble Grenoble, France
View all 23 locations
View Trial Details
Completed

Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)

NCT03364036

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Liverpool Hospital Sydney, New South Wales, Australia
  • John Hunter Hospital Hunter Region Mail Centre, Australia
  • Perron Institute - Neurology Nedlands, Australia
  • The Alfred Hospital Prahran, Australia
View all 54 locations
View Trial Details
Completed

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT02073279

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • University of Colorado Denver -; Neurology Aurora, Colorado, United States
  • University of Miami UHealth Professional Arts Center Miami, Florida, United States
  • The MS Center of Vero Beach Vero Beach, Florida, United States
  • Columbus Research and Wellness Columbus, Georgia, United States
View all 58 locations
View Trial Details
Completed

Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT02629796

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP, +12 more
Locations
  • CHU Bordeaux, service de Neurologie Bordeaux, Aquitaine, France
  • CHU Nantes, Laboratoire d'explorations fonctionnelles Nantes, Loire Atlantique, France
  • CHU de Brest Brest, France
  • CHU de CAEN Caen, France
View all 18 locations
View Trial Details

Related conditions